22.04.2015 08:00:00
|
First Quarter Trading Update
Regulatory News:
22 April 2015
RELX Group, the global professional information company, has issued a trading update and reaffirmed the outlook for the full year.
|
Scientific, Technical & Medical
- Our customer environment remains largely unchanged. Key business trends remained positive in the first quarter. In primary research, growth in article submissions and usage remained strong across the scientific, technical and medical segments.
- Full year outlook: Overall we expect another year of modest underlying revenue growth.
Risk & Business Information
- The fundamental growth drivers of Risk & Business Information remain strong, with strong revenue growth across all key segments in the first quarter. The Insurance segment saw continued growth in the US auto and newer adjacent markets, and positive momentum continued in Business Services, Government, Healthcare, and Data Services.
- Full year outlook: We expect underlying revenue growth trends to continue.
Legal
- Trends in our major customer markets are unchanged. The roll-out of new platform releases and usage have continued to progress well.
- Full year outlook: Market conditions continue to limit the scope for underlying revenue growth. We will maintain our focus on process innovation, and expect further improvement in profitability over the medium term.
Exhibitions
- Underlying revenue growth in the first quarter remained strong in the US and Japan and modest in Europe. Most other markets remain strong, albeit slightly below the high levels achieved in recent years.
- Full year outlook: We expect current trends to continue, and cycling effects to reduce the overall revenue growth rate by three to four percentage points.
-ENDS-
FORWARD-LOOKING STATEMENTS
This Results Announcement contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms "outlook”, "estimate”, "project”, "plan”, "intend”, "expect”, "should be”, "will be”, "believe”, "trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to, competitive factors in the industries in which RELX Group operates; demand for RELX Group’s products and services; exchange rate fluctuations; general economic and business conditions; legislative, fiscal, tax and regulatory developments and political risks; the availability of third party content and data; breaches of our data security systems and interruptions in our information technology systems; changes in law and legal interpretations affecting RELX Group’s intellectual property rights and other risks referenced from time to time in the filings of RELX Group with the US Securities and Exchange Commission.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu RELX PLC (ex Reed Elsevier)mehr Nachrichten
15:59 |
Optimismus in Europa: STOXX 50 verbucht am Nachmittag Zuschläge (finanzen.at) | |
12:27 |
Starker Wochentag in Europa: STOXX 50 mittags in Grün (finanzen.at) | |
09:29 |
Gewinne in Europa: STOXX 50 liegt zum Start im Plus (finanzen.at) | |
20.12.24 |
Verluste in Europa: STOXX 50 zeigt sich zum Start schwächer (finanzen.at) | |
18.12.24 |
Pluszeichen in Europa: STOXX 50 legt zum Handelsende zu (finanzen.at) | |
18.12.24 |
FTSE 100-Papier RELX-Aktie: So viel hätten Anleger an einem RELX-Investment von vor 3 Jahren verdient (finanzen.at) | |
18.12.24 |
Schwacher Handel: STOXX 50 fällt zum Start zurück (finanzen.at) | |
11.12.24 |
Börse Europa: STOXX 50 zeigt sich nachmittags fester (finanzen.at) |
Analysen zu RELX PLC (ex Reed Elsevier)mehr Analysen
11.12.24 | RELX Overweight | JP Morgan Chase & Co. | |
08.11.24 | RELX Overweight | JP Morgan Chase & Co. | |
31.10.24 | RELX Buy | UBS AG | |
24.10.24 | RELX Outperform | Bernstein Research | |
10.10.24 | RELX Overweight | JP Morgan Chase & Co. |